Administration

行政

基本信息

项目摘要

The Administrative, Biostatistics, and Clinical Support Core (A) will provide the infrastructure support for the basic and clinical research components of this program. The Administrative component of the core will coordinate the overall interactions among the research projects and core facilities. This will include preparation of manuscripts and progress reports and maintaining the ongoing calendar of weekly research meetings among the program's investigators to facilitate regular review of the progress of the component projects. In addition, this component of the core will maintain the calendar of biweekly strategic planning meetings among the project leaders to discuss issues related to the long-range goals of the individual projects and their interactions with the overall program, and will coordinate periodic oversight of the program by the internal and external advisory groups composed of scientists with expertise relevant to the program. The administrative component will also be responsible for overall budgetary issues of the program, for coordinating interactions between the program and other administrative entities within the institution, and for providing logistical and scientific support to facilitate progress of the component projects. This core will promote the involvement and interactions of each project with a biostatistician, who has worked closely with the investigators of this program from its outset. This Biostatistics component of the core will ensure that appropriate statistical parameters are incorporated in the design of the studies of the program, so that in vitro, animal, and patient resources are used efficiently, and that rigorous methods are applied for the interpretation and reporting of the results of preclinical and clinical studies. This core will also coordinate the Clinical Support for therapeutic studies conducted within the context of this program by facilitating timely submission of protocols for institutional peer review, maintaining compliance with institutional and federal guidelines, and ensuring that the clinical aspects of this program are integrated seamlessly with the extensive existing resources available within the University of Pittsburgh Cancer Institute. Relevance: This core will provide the essential administrative, biostatistical and clinical support expertise needed to facilitate the research mission of the projects and other cores within this program.
行政、生物统计和临床支持核心(A)将提供基础设施

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ian F. Pollack其他文献

A comprehensive evaluation of career trajectories of the American Association of Neurological Surgeons William P. Van Wagenen fellows
  • DOI:
    10.1016/j.wnsx.2024.100365
  • 发表时间:
    2024-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Tritan Plute;Othman Bin-Alamer;Arka N. Mallela;Justiss A. Kallos;D. Kojo Hamilton;Ian F. Pollack;L. Dade Lunsford;Robert M. Friedlander;Hussam Abou-Al-Shaar
  • 通讯作者:
    Hussam Abou-Al-Shaar
Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapy
靶向转录本的抗原作图揭示了 POSTN 剪接连接表位在胶质母细胞瘤免疫治疗中的潜力
  • DOI:
    10.1038/s41435-025-00326-6
  • 发表时间:
    2025-04-03
  • 期刊:
  • 影响因子:
    4.500
  • 作者:
    Zujian Xiong;Chaim T. Sneiderman;Chloe R. Kuminkoski;Jared Reinheimer;Lance Schwegman;ReidAnn E. Sever;Ahmed Habib;Baoli Hu;Sameer Agnihotri;Dhivyaa Rajasundaram;Pascal O. Zinn;Thomas G. Forsthuber;Ian F. Pollack;Xuejun Li;Itay Raphael;Gary Kohanbash
  • 通讯作者:
    Gary Kohanbash
Outcome following hindbrain decompression of symptomatic Chiari malformations in children previously treated with myelomeningocele closure and shunts.
对先前接受脊髓脊膜膨出闭合和分流治疗的儿童有症状的 Chiari 畸形进行后脑减压后的结果。
  • DOI:
    10.3171/jns.1992.77.6.0881
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Ian F. Pollack;Dachling Pang;A. Albright;Donald Krieger
  • 通讯作者:
    Donald Krieger
The current landscape of immunotherapy for pediatric brain tumors
儿童脑肿瘤免疫治疗的现状
  • DOI:
    10.1038/s43018-021-00319-0
  • 发表时间:
    2022-01-20
  • 期刊:
  • 影响因子:
    28.500
  • 作者:
    Eugene I. Hwang;Elias J. Sayour;Catherine T. Flores;Gerald Grant;Robert Wechsler-Reya;Lan B. Hoang-Minh;Mark W. Kieran;Joanne Salcido;Robert M. Prins;John W. Figg;Michael Platten;Kate M. Candelario;Paul G. Hale;Jason E. Blatt;Lance S. Governale;Hideho Okada;Duane A. Mitchell;Ian F. Pollack
  • 通讯作者:
    Ian F. Pollack
Does machine learning improve prediction accuracy of the Endoscopic Third Ventriculostomy Success Score? A contemporary Hydrocephalus Clinical Research Network cohort study
  • DOI:
    10.1007/s00381-024-06667-3
  • 发表时间:
    2024-12-10
  • 期刊:
  • 影响因子:
    1.200
  • 作者:
    Armaan K. Malhotra;Abhaya V. Kulkarni;Leonard H. Verhey;Ron W. Reeder;Jay Riva-Cambrin;Hailey Jensen;Ian F. Pollack;Michael McDowell;Brandon G. Rocque;Mandeep S. Tamber;Patrick J. McDonald;Mark D. Krieger;Jonathan A. Pindrik;Albert M. Isaacs;Jason S. Hauptman;Samuel R. Browd;William E. Whitehead;Eric M. Jackson;John C. Wellons;Todd C. Hankinson;Jason Chu;David D. Limbrick;Jennifer M. Strahle;John R. W. Kestle
  • 通讯作者:
    John R. W. Kestle

Ian F. Pollack的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ian F. Pollack', 18)}}的其他基金

Peptide vaccine immunotherapy for children with recurrent low-grade astrocytomas
肽疫苗免疫治疗儿童复发性低度星形细胞瘤
  • 批准号:
    9027315
  • 财政年份:
    2016
  • 资助金额:
    $ 16.61万
  • 项目类别:
Peptide vaccine-based immunotherapy for children with recurrent ependymomas.
基于肽疫苗的免疫疗法治疗复发性室管膜瘤儿童。
  • 批准号:
    8658814
  • 财政年份:
    2013
  • 资助金额:
    $ 16.61万
  • 项目类别:
Peptide vaccine-based immunotherapy for children with recurrent ependymomas.
基于肽疫苗的免疫疗法治疗复发性室管膜瘤儿童。
  • 批准号:
    8868955
  • 财政年份:
    2013
  • 资助金额:
    $ 16.61万
  • 项目类别:
Peptide vaccine-based immunotherapy for children with recurrent ependymomas.
基于肽疫苗的免疫疗法治疗复发性室管膜瘤儿童。
  • 批准号:
    8478400
  • 财政年份:
    2013
  • 资助金额:
    $ 16.61万
  • 项目类别:
Gene Therapy of Malignant Gliomas: A Phase I Study
恶性胶质瘤的基因治疗:一期研究
  • 批准号:
    6974663
  • 财政年份:
    2004
  • 资助金额:
    $ 16.61万
  • 项目类别:
CORE -- BIOSTATISTICS /CLINICAL SUPPORT
核心——生物统计学/临床支持
  • 批准号:
    6616011
  • 财政年份:
    2002
  • 资助金额:
    $ 16.61万
  • 项目类别:
Novel Strategies for Brain Tumor Therapy
脑肿瘤治疗新策略
  • 批准号:
    6786053
  • 财政年份:
    2002
  • 资助金额:
    $ 16.61万
  • 项目类别:
Administration
行政
  • 批准号:
    8074417
  • 财政年份:
    2002
  • 资助金额:
    $ 16.61万
  • 项目类别:
Signal transduction modulation as a therapy for malignant gliomas
信号转导调节作为恶性神经胶质瘤的治疗方法
  • 批准号:
    8232994
  • 财政年份:
    2002
  • 资助金额:
    $ 16.61万
  • 项目类别:
Administration
行政
  • 批准号:
    8377649
  • 财政年份:
    2002
  • 资助金额:
    $ 16.61万
  • 项目类别:

相似海外基金

HNDS-R: Connectivity, Inclusiveness, and the Permeability of Basic Science
HNDS-R:基础科学的连通性、包容性和渗透性
  • 批准号:
    2318404
  • 财政年份:
    2023
  • 资助金额:
    $ 16.61万
  • 项目类别:
    Standard Grant
Advancing the basic science of membrane permeability in macrocyclic peptides
推进大环肽膜渗透性的基础科学
  • 批准号:
    10552484
  • 财政年份:
    2023
  • 资助金额:
    $ 16.61万
  • 项目类别:
Computer Vision for Malaria Microscopy: Automated Detection and Classification of Plasmodium for Basic Science and Pre-Clinical Applications
用于疟疾显微镜的计算机视觉:用于基础科学和临床前应用的疟原虫自动检测和分类
  • 批准号:
    10576701
  • 财政年份:
    2023
  • 资助金额:
    $ 16.61万
  • 项目类别:
Bringing together communities and basic science researchers to build stronger relationships
将社区和基础科学研究人员聚集在一起,建立更牢固的关系
  • 批准号:
    480914
  • 财政年份:
    2023
  • 资助金额:
    $ 16.61万
  • 项目类别:
    Miscellaneous Programs
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
  • 批准号:
    FL210100071
  • 财政年份:
    2022
  • 资助金额:
    $ 16.61万
  • 项目类别:
    Australian Laureate Fellowships
Developing science communication on large scale basic science represented by accelerator science
发展以加速器科学为代表的大规模基础科学科学传播
  • 批准号:
    22K02974
  • 财政年份:
    2022
  • 资助金额:
    $ 16.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
早期病变转化和基础科学研究协调和数据管理中心
  • 批准号:
    10517004
  • 财政年份:
    2022
  • 资助金额:
    $ 16.61万
  • 项目类别:
Basic Science Core - Imaging
基础科学核心 - 成像
  • 批准号:
    10588228
  • 财政年份:
    2022
  • 资助金额:
    $ 16.61万
  • 项目类别:
UCSF - UCB TRAC Basic Science CORE
UCSF - UCB TRAC 基础科学核心
  • 批准号:
    10674711
  • 财政年份:
    2022
  • 资助金额:
    $ 16.61万
  • 项目类别:
Basic Science Core - Biosafety & Biocontainment Core (BBC)
基础科学核心 - 生物安全
  • 批准号:
    10431468
  • 财政年份:
    2022
  • 资助金额:
    $ 16.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了